Development and validation of a high-quality composite real-world mortality endpoint Published June 2018 Citation Curtis, M.D., Griffith, S.D., Tucker, M, Taylor, M.D., Capra, W.B., Carrigan, G, Holzman, B, Torres, A.Z., You, P, Arnieri, B, Abernethy, A.P. . Academy Health Annual Research Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/FH_AH_2018_poster_final.pdf Authors: Sources:Academy Health Annual Research Meeting Share Posted inPublicationsMethodology More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerESMO Real-World Data and Digital OncologyFebruary 2025Characterisation of oncology EHR-derived real-world data in the UK, Germany, and JapanAdamson B, Horne E, Xu C, et al.Real-world evidencePublication summaryPublicationsData scienceMethodologyHTA and market accessJCO Cancer Clinical InformaticsMarch 2026Impact of real-world response to first-line immunotherapy and chemotherapy on subsequent treatment outcomes in patients with advanced or metastatic non-small cell lung cancerMalhotra J, Viswanathan S, Mhatre S, et al. Publication summaryPublicationsTreatment patternsNon-small cell lung cancer